Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication of advertisements in respect of certain matters relating to the Rights Issue of equity shares of the Company
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises Limited (HCG) has published newspaper advertisements regarding its Rights Issue, in compliance with SEBI ICDR Regulation 84. The company is issuing up to 82,94,566 fully paid-up equity shares of face value ₹10 each at a price of ₹512 per share (including ₹502 premium), aggregating up to ₹424.68 crores. The ratio is 1 rights share for every 17 shares held, with the record date set as March 2, 2026. The issue opens on March 11, 2026 and closes on March 25, 2026, with the last date for on-market renunciation being March 20, 2026. The Letter of Offer was dispatched on March 4, 2026, and the advertisements were published in Financial Express, Jansatta, and Vishwavani. Promoters include AHealth Asia Holdings II Pte. Ltd., Catalyst Trusteeship Limited, and Dr. B.S. Ajaikumar.
Eligible shareholders as of the record date can subscribe to the rights issue at ₹512 per share to maintain their proportional ownership. Shareholders who do not wish to subscribe can renounce their rights entitlements on or off the market until March 20, 2026. The issue is priced at 89 times face value and could lead to short-term dilution if not fully subscribed.